M. Abe
Kyoto University
56 Papers
559 Citations
M. Abe is an academic researcher from Kyoto University. The author has contributed to research in topics: Radiation therapy & Hyperthermia. The author has an hindex of 14, co-authored 55 publications.
Chat about Author
Papers
Localized hyperthermia and radiation in cancer therapy
M. Abe,Masahiro Hiraoka +1 more
TL;DR: Background information on the biological rationale and current status of technologies concerning thermometry and heating equipment for the application of hyperthermia to human cancer treatment and results so far published have demonstrated that local control is consistently better in the lesions treated with radiation plus heat than with radiation alone are provided.
55
•Journal Article
Monitoring liver tumor therapy with [18F]FDG positron emission tomography.
Yasushi Nagata,Kimiyo N. Yamamoto,Masahiro Hiraoka,M. Abe,M. Takahashi,Keizo Akuta,Yasumasa Nishimura,Shiken Jo,S. Masunaga,Shigeto Kubo,J Konishi +10 more
TL;DR: Three cases are reported in which PET-FDG was more useful for monitoring liver tumor therapy than other imaging methods and tumor markers.
54
Evaluation of Various Types of New Hypoxic Cell Sensitizers Using the EMT6 Single Cell—Spheroid—Solid Tumour System
TL;DR: Eleven new hypoxic cell sensitizers representative of those developed in Japan between 1980 and 1985 were evaluated in vitro and in vivo in comparison with misonidazole (MISO), SR-2508, Ro 03-8799, and ANT (2-amino-5-nitrothiazole).
53
Clinical results of thermoradiotherapy for locally advanced and/or recurrent breast cancer--comparison of results with radiotherapy alone.
Shin-ichiro Masunaga,Masahiro Hiraoka,M. Takahashi,Shiken Jo,Keizo Akuta,Yasumasa Nishimura,Yasushi Nagata,M. Abe +7 more
TL;DR: The thermal profiles showed that the capability of an RF capacitive heating device is comparatively high for large breast tumours with a volume of more than 100 cm3, and that of a 430 MHz microwave device with a single-lens applicator is excellent for localized tumours.
46
Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer
Shin-ichiro Masunaga,Masahiro Hiraoka,Keizo Akuta,Yasumasa Nishimura,Yasushi Nagata,Shiken Jo,M. Takahashi,M. Abe,Toshiro Terachi,K. Oishi,Osamu Yoshida +10 more
TL;DR: Patients with T3-4 or grade 3 bladder cancer in group 2 had a longer average survival than those in group 1, although the difference was not significant and the toxicity associated with hyperthermia was pain during treatment, and complications were not serious.
40